Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry

Kuemmerle-Deschner J, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Kallinich T, Weller-Heinemann F, Horneff G, Foeldvari I, Schuetz C, Borte M, Braner A, Weber-Arden J, Blank N (2021)


Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 381-382

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Kuemmerle-Deschner, J., Kortus-Goetze, B., Oommen, P.T., Janda, A., Rech, J., Kallinich, T.,... Blank, N. (2021). Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry. In ARTHRITIS & RHEUMATOLOGY (pp. 381-382). HOBOKEN: WILEY.

MLA:

Kuemmerle-Deschner, Jasmin, et al. "Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2021. 381-382.

BibTeX: Download